SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-000220
Filing Date
2022-01-11
Accepted
2022-01-10 17:31:55
Documents
13
Period of Report
2022-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bcab-20220105.htm   iXBRL 8-K 52575
2 EX-99.1 bcab-ex99_1.htm EX-99.1 25282
  Complete submission text file 0000950170-22-000220.txt   196992

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bcab-20220105.xsd EX-101.SCH 2492
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bcab-20220105_pre.xml EX-101.PRE 9543
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bcab-20220105_lab.xml EX-101.LAB 12890
7 EXTRACTED XBRL INSTANCE DOCUMENT bcab-20220105_htm.xml XML 4518
Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Filer) CIK: 0001826892 (see all company filings)

IRS No.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39787 | Film No.: 22522169
SIC: 2836 Biological Products, (No Diagnostic Substances)